Daxor Corporation (DXR) Financials

DXR Assets vs Liabilities

DateAssetsLiabilities
Dec. 31, 2023 34.9 million 858758
June 30, 2023 30.4 million ?
March 31, 2023 30.4 million ?
Dec. 31, 2022 30.3 million 1.3 million

DXR Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Dec. 31, 2023 -3.8 million ?
June 30, 2023 -2.6 million 162137
March 31, 2023 -1.4 million 162137
Dec. 31, 2022 -1.9 million 255576

DXR Net Income

Graph available only for paid members. Upgrade to see it.
DateNet Income
Dec. 31, 2023 3.3 million
June 30, 2023 -3.0 million
March 31, 2023 -1.5 million
Dec. 31, 2022 7.0 million

DXR Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Dec. 31, 2023 - - -
June 30, 2023 - - -
March 31, 2023 - - -
Dec. 31, 2022 - - -

DXR Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Dec. 31, 2023 4.8 million
June 30, 2023 4.5 million
March 31, 2023 4.8 million
Dec. 31, 2022 4.1 million

DXR Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Dec. 31, 2023 - - - -
June 30, 2023 - - 218024 -
March 31, 2023 - - 218024 -
Dec. 31, 2022 - - 360721 -

DXR Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Dec. 31, 2023 36.4 million -4636
June 30, 2023 -1.8 million 439316
March 31, 2023 40487 -
Dec. 31, 2022 -324140 726183

DXR

Price: $10.90

52 week price:
8.56
14.76

Earnings Per Share: 0.16 USD

P/E Ratio: 72.75

Exchange: NCM

Sector: Healthcare

Industry: Medical Instruments & Supplies

Country: United States

Volume: 5100

Market Capitalization: 53.1 million

Links: